Average Co-Inventor Count = 8.50
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. The United States of America, as Represented by the Secretary, Department of Health and Human Services (13 from 3,540 patents)
2. Novartis Ag (2 from 3,924 patents)
3. Genzyme Corporation (2 from 789 patents)
4. Glaxosmithkline Biologicals Sa (2 from 531 patents)
5. Janssen Vaccines & Prevention B.v. (1 from 115 patents)
6. Norvartis Ag (1 from 3 patents)
7. Sabin Vaccine Institute (1 from 1 patent)
8. Genvec, Inc. (88 patents)
19 patents:
1. 12486524 - Methods of culturing a mammalian cell
2. 12458691 - HIV-1 ENV fusion peptide immunogens and their use
3. 12145968 - Recombinant HIV-1 envelope proteins and their use
4. 12053520 - Glycan-masked engineered outer domains of HIV-1 gp120 and their use
5. 11939356 - Self-assembling insect ferritin nanoparticles
6. 11913013 - Chimpanzee adenoviral vector-based filovirus vaccines
7. 11602559 - HIV-1 Env fusion peptide immunogens and their use
8. 11459360 - Recombinant HIV-1 envelope proteins and their use
9. 11306341 - Methods of culturing a mammalian cell
10. 11235056 - Glycan-masked engineered outer domains of HIV-1 gp120 and their use
11. 11136356 - Recombinant HIV-1 envelope proteins and their use
12. 10961283 - Self-assembling insect ferritin nanoparticles for display of co-assembled trimeric antigens
13. 10584355 - Chimpanzee adenoviral vector-based filovirus vaccines
14. 10400015 - Recombinant HIV-1 envelope proteins and their use
15. 9701718 - Adenovirus serotype 26 and serotype 35 filovirus vaccines